Zobrazeno 1 - 10
of 766
pro vyhledávání: '"Takuji Okusaka"'
Autor:
Hidenobu Hara, MD, Susumu Hijioka, MD, Yoshikuni Nagashio, MD, Yuta Maruki, MD, Mark Chatto, MD, Yutaka Saito, MD, Takuji Okusaka, MD
Publikováno v:
VideoGIE, Vol 9, Iss 6, Pp 286-289 (2024)
Externí odkaz:
https://doaj.org/article/351d74f0100a48c7883a97eef7cb29c7
Autor:
Kotaro Takeshita, Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Akihiro Ohba, Yuki Kawasaki, Tetsuro Takasaki, Shin Yagi, Daiki Agarie, Hidenobu Hara, Yuya Hagiwara, Daiki Yamashige, Kohei Okamoto, Soma Fukuda, Masaru Kuwada, Mark Chatto, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Yutaka Saito, Takuji Okusaka
Publikováno v:
Endoscopy International Open, Vol 12, Iss 07, Pp E875-E886 (2024)
Externí odkaz:
https://doaj.org/article/ff8f6d1c0de6450cadbb77cad3534b70
Autor:
Soma Fukuda, Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Akihiro Ohba, Daiki Agarie, Yuya Hagiwara, Hidenobu Hara, Kohei Okamoto, Daiki Yamashige, Shin Yagi, Masaru Kuwada, Mark Chatto, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Yutaka Saito, Takuji Okusaka
Publikováno v:
Endoscopy International Open, Vol 12, Iss 06, Pp E715-E722 (2024)
Externí odkaz:
https://doaj.org/article/ef64cd618e89467cb0c5db14e776845d
Autor:
Hiroshi Imaoka, Masafumi Ikeda, Shogo Nomura, Chigusa Morizane, Takuji Okusaka, Masato Ozaka, Satoshi Shimizu, Kentaro Yamazaki, Naohiro Okano, Kazuya Sugimori, Hirofumi Shirakawa, Nobumasa Mizuno, Sohei Satoi, Hironori Yamaguchi, Rie Sugimoto, Kunihito Gotoh, Keji Sano, Akinori Asagi, Kazuyoshi Nakamura, Makoto Ueno
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract The prognosis of advanced biliary tract cancer (BTC) patients remains poor due to limited efficacy of chemotherapy and difficulties in management. Thus, prediction of survival is crucial for the clinical management of advanced BTC. The aim w
Externí odkaz:
https://doaj.org/article/e3baf138902d49fc89d0cce9781a3f2f
Autor:
Daiki Yamashige, Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Soma Fukuda, Shin Yagi, Kohei Okamoto, Hidenobu Hara, Yuya Hagiwara, Daiki Agarie, Tetsuro Takasaki, Mark Chatto, Akihiro Ohba, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Miyuki Sone, Yutaka Saito, Takuji Okusaka
Publikováno v:
Endoscopy International Open, Vol 12, Iss 03, Pp E367-E376 (2024)
Externí odkaz:
https://doaj.org/article/f1f83595aa4d405397deb4014e967eb4
Autor:
Takuji Okusaka, Shunsuke Kondo, Chigusa Morizane, Tetsuro Takasaki, Hideki Ueno, Yuki Kawasaki, Susumu Hijioka, Yoshikuni Nagashio, Akihiro Ohba, Yuta Maruki, Kotaro Takeshita, Shin Yagi, Daiki Agarie, Yuya Hagiwara, Hidenobu Hara, Kohei Okamoto, Daiki Yamashige, Souma Fukuda, Masaru Kuwada
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Introduction The current endoscopic treatment for postoperative benign hepaticojejunostomy anastomotic stricture (HJAS) has a high technical success rate and is highly effective in the short term. However, long-term results have shown a high rate of
Externí odkaz:
https://doaj.org/article/f5de06bf7dca4fc58268470d5c7867eb
Autor:
Masatoshi Kudo, Richard S. Finn, Masafumi Ikeda, Max W. Sung, Ari D. Baron, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, Marc Pracht, Tim Meyer, Satoshi Nagao, Kenichi Saito, Kalgi Mody, Zahra Ramji, Leonid Dubrovsky, Josep M. Llovet
Publikováno v:
Liver Cancer (2023)
Background: Treatment with lenvatinib (dosing for patients who weigh ≥60 kg was 12 mg/day; for patients who weigh
Externí odkaz:
https://doaj.org/article/9b3dbb00ba7849bcbc864150e49a693b
Autor:
Takuji Okusaka, Manabu Morimoto, Yuichiro Eguchi, Shinichiro Nakamura, Shuichi Iino, Rie Kageyama
Publikováno v:
Drugs in R&D, Vol 23, Iss 2, Pp 99-107 (2023)
Abstract Background and Objective For patients with advanced hepatocellular carcinoma (HCC), the standard of care for many years has been sorafenib. Preliminary data have suggested that the combination of the NAD(P)H:quinone oxidoreductase 1 bioactiv
Externí odkaz:
https://doaj.org/article/cbcd82c94c8148c2b3a59433e972d513
Autor:
Shun Yamamoto, Naoki Sakakibara, Hidekazu Hirano, Chigusa Morizane, Yoshitaka Honma, Susumu Hijioka, Takuji Okusaka, Takahiro Higashi, Akira Kawai
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract In November 2013, the first edition of evidence-based guidelines for treatment of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) was published in Japan. However, whether medical practitioners have adopted the first-line regimens re
Externí odkaz:
https://doaj.org/article/2fbf770325db4322866fff97da0ca57d
Autor:
Stephen L. Chan, Martin Schuler, Yoon-Koo Kang, Chia-Jui Yen, Julien Edeline, Su Pin Choo, Chia-Chi Lin, Takuji Okusaka, Karl-Heinz Weiss, Teresa Macarulla, Stéphane Cattan, Jean-Frederic Blanc, Kyung-Hun Lee, Michela Maur, Shubham Pant, Masatoshi Kudo, Eric Assenat, Andrew X. Zhu, Thomas Yau, Ho Yeong Lim, Jordi Bruix, Andreas Geier, Carmen Guillén-Ponce, Angelica Fasolo, Richard S. Finn, Jia Fan, Arndt Vogel, Shukui Qin, Markus Riester, Vasiliki Katsanou, Monica Chaudhari, Tomoyuki Kakizume, Yi Gu, Diana Graus Porta, Andrea Myers, Jean-Pierre Delord
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-19 (2022)
Abstract Background Deregulation of FGF19-FGFR4 signaling is found in several cancers, including hepatocellular carcinoma (HCC), nominating it for therapeutic targeting. FGF401 is a potent, selective FGFR4 inhibitor with antitumor activity in preclin
Externí odkaz:
https://doaj.org/article/1a80d93b46254b83bfdf5d4c0de1a368